USD
+$0.00
(+0.00%
)At Close (As of Sep 16, 2025)
$27.36M
Market Cap
-
P/E Ratio
-2.16
EPS
$4.59
52 Week High
$1.83
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$504K |
Total Revenue | $9.8K |
Cost Of Revenue | $513K |
Costof Goods And Services Sold | $513K |
Operating Income | -$23M |
Selling General And Administrative | $8.4M |
Research And Development | $14M |
Operating Expenses | $9.2M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $42K |
Income Before Tax | -$4.1M |
Income Tax Expense | -$4B |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$4.1M |
Comprehensive Income Net Of Tax | - |
Ebit | -$23M |
Ebitda | -$23M |
Net Income | -$4.1M |
Field | Value (USD) |
---|---|
Total Assets | $22M |
Total Current Assets | $18M |
Cash And Cash Equivalents At Carrying Value | $16M |
Cash And Short Term Investments | $16M |
Inventory | - |
Current Net Receivables | $230K |
Total Non Current Assets | $3.7M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $16B |
Other Current Assets | $2.5M |
Other Non Current Assets | - |
Total Liabilities | $28M |
Total Current Liabilities | $22M |
Current Accounts Payable | $1.5M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.1M |
Total Non Current Liabilities | $6.5M |
Capital Lease Obligations | $1.3M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $1.3M |
Other Current Liabilities | $2.5M |
Other Non Current Liabilities | $4.7M |
Total Shareholder Equity | -$6M |
Treasury Stock | - |
Retained Earnings | -$175M |
Common Stock | $870 |
Common Stock Shares Outstanding | $8.5M |
Field | Value (USD) |
---|---|
Operating Cashflow | $5.4M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $42K |
Capital Expenditures | $573K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$573K |
Cashflow From Financing | $434K |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$4.1M |
Field | Value (USD) |
---|---|
Gross Profit | -$504K |
Total Revenue | $9.8K |
Cost Of Revenue | $513K |
Costof Goods And Services Sold | $513K |
Operating Income | -$23M |
Selling General And Administrative | $8.4M |
Research And Development | $14M |
Operating Expenses | $9.2M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $42K |
Income Before Tax | -$4.1M |
Income Tax Expense | -$4B |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$4.1M |
Comprehensive Income Net Of Tax | - |
Ebit | -$23M |
Ebitda | -$23M |
Net Income | -$4.1M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States. The company is headquartered in San Diego, California.